Expanded scope of technology alliance to advance healthcare innovation across the enterprise, now including bedside monitoring, telemetry and ambulatory monitoring solutions, maternal-infant care, and advanced perioperative monitoring

Builds on longstanding global collaboration focused on empowering clinicians and transforming patient care through advanced technology and clinical excellence

Medtronic today announced a multi-year renewal and significant expansion of its global strategic alliance with GE HealthCare across Patient Care Solutions. Building on over three decades of healthcare technology collaboration, this global agreement expansion is intended to accelerate clinical and technology innovation and enable healthcare providers to deliver smart, safe, and efficient care across hospital environments.

The longstanding alliance is also taking aim at future innovations, with a plan to adopt next-generation Medtronic technologies across GE HealthCare’s Patient Care Solutions platforms, including expansion into wireless wearable solutions and anesthesia airway visualization.

“Our expanded alliance with GE HealthCare reflects our commitment to empowering healthcare professionals with world-class technology to personalize patient care, anytime, anywhere,” said Kate Benedict, president of the Medtronic Acute Care & Monitoring business, which is part of the company’s Medical Surgical Portfolio. “Expanding access to our combined technologies and commercial solutions allows hospitals to streamline their operations, reduce inefficiencies, and ultimately empower clinicians to focus on what matters most: their patients.”

Key to the collaboration is the broad integration of clinically advanced monitoring parameters from Medtronic — Nellcor™ pulse oximetry, Microstream™ capnography, INVOS™ regional oximetry, and BIS™ brain monitoring — across all of GE HealthCare’s Monitoring Solutions platforms and including Maternal-Infant Care. This technology collaboration extends to GE HealthCare’s FlexAcuity™ platforms, CARESCAPE Canvas™ and Carevance™ monitors. These integrations support patient-adaptable monitoring and enable efficient patient care that allow clinicians to tailor treatments to individual patient needs and care settings.

Technology and clinical partnerships are key to advancing healthcare innovation. That’s why Medtronic and GE HealthCare have further committed to expediting adoption of Medtronic next-generation Nellcor™ pulse oximetry and BIS™ Advance technologies across multiple platforms, with the intent to deliver accurate and inclusive care across all patient populations.

“We are excited to continue to collaborate with GE HealthCare to bring our newest innovations in wireless wearable monitoring and seamless streaming video laryngoscopy from Medtronic to GE HealthCare’s anesthesia and monitoring platforms,” said Jason Case, vice president of research and development for Medtronic Acute Care & Monitoring. “Expanding our deep, long-standing strategic alliance with GE HealthCare helps ensure timely access to the latest innovative technologies for both clinicians and their patients.”

The renewed multiyear global strategic alliance also includes expanded commercial initiatives between Medtronic Acute & Monitoring and GE HealthCare Patient Care Solutions, designed to accelerate clinical transformation, reduce costs, and harmonize technology platforms. Together, the partnership aims to deliver integrated enterprise solutions that enhance patient outcomes and drive innovation across the continuum of care.

Acute Care and Monitoring products should not be used as the sole basis for diagnosis or therapy and are intended only as an adjunct in patient assessment.

About Medtronic

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Amanda Bartschenfeld
Communications
amanda.k.bartschenfeld@medtronic.com

Ingrid Goldberg
Investor Relations
investorrelations@medtronic.com